Pathophysiology of Anxiety and Sleep disorders Flashcards

1
Q

what is a sedative

A

Calms anxiety, decreases excitement and activity, does not produce drowsiness, or impair performance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a Anxiolytic

A

Antianxiety, relieves anxiety without sleep or sedation (not all anxiolytics are sedatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a Hypnotic

A

Induces sleep, implies restful, refreshing sleep, not “hypnotized!”, natural sleep (medial use term: sleeping-inducing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is a Narcotic

A

Actually means “sleep producing”, now refers to opioids or illegal drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the reticular formation

A

The reticular formation extends through the central core of the medulla oblongata pons and midbrain it is an intricate system composed of loosely clustered neurons in what is otherwise white matter
very complex contains dopamine adrenergic serotonergic and cholinergic neurons regulates sleep-wake transitions and synchronization of EEG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the stages of sleep

A

Wakefulness
Non-rapid eye movement (NREM) slow-wave sleep
Rapid eye movement (REM) sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is NREM sleep

A

NREM sleep
– Stage 1 (dozing)
– Stage 2 (unequivocal sleep)
– Stage 3 (voltage increase, frequency decrease)
– Stage 4 (delta waves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What factors regulate sleep

A

Age: Decreases with age due to changes in activity of reticular formation
Sleep History: Rebound of REM sleep
Drug Ingestion: Acute and withdrawal produce rebound effects
Circadian Rhythms: “Normal sleep cycle”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the biological regulators of sleep

A

Neurotransmitters (almost all): Catecholamines (e.g., epinephrine, norepinephrine, and dopamine), Serotonin (5HT), Histamine, Acetylcholine (ACh), Adenosine
GABA (main target for current medications)
Neuromodulators: Growth Hormone (GH), Prolactin, Cortisol, Melatonin — “hormone of darkness” Endogenous Peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GABAergic Neurotransmission

A

GABAA Receptors
GABAB Receptors
GABA Transporters (GAT-1)
GABA-T (Transaminase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GABAa receptor structure

A

Pentameric structure comprised of 5 subunits from several polypeptide
classes
many subtypes a1, a2,a3,a5, bx, and yx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GABAA Receptor/Chloride Ion Channel Complex Targets for Sedative-Hypnotics

A

Orthosteric site: GABA (a1 and b2)
Allosteric Sites benzodiazepine (BZD) site (a1 and g2)
-Barbiturate
-Ethanol
-Glucocorticoid
Channel pore (picrotoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ligands Acting at the BZD Receptor

A

Benzodiazepines: Facilitate GABA action (e.g., a1-5), increase
frequency
Non-Benzodiazepines (Z-Hypnotics): zolpidem (Ambien®), zaleplon (Sonata®), eszopiclone (LunestaTM) – BZ1 receptors of a1
BZD Antagonists: flumazenil (Romazicon®), overdose treatment
Inverse BZD Agonists: B carbolines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Modulation of the GABAA Receptor

A

Ligands acting at “other” non-orthosteric sites
A. BZDs: Increase frequency of channel opening,
B. Barbiturtates (Bbt): Increase duration of channel opening, and direct effects on GABAA (high doses)
C. Alcohol: Enhances actions of GABA at GABAA receptor
D. GABA channel blockers: picrotoxin
E. Etomidate and Propofol (Diprovan; aka “milk of
amnesia”): b2 and b3 subunit containing receptors
F. Neurosteroids (e.g., progesterone and deoxycortisone)
for treating depression, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Structure Activity Relationships of Benzodiazepines:

A

1 Position alkylation source of active metabolites
Annealating the 1-2 bond with an “electron rich” ring (triazole or
imidazole) yields high affinity and decreased half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which drugs have a slow elimination rate (benzodiazepines)

A

Chlordiazepoxide (Librium®)
Diazepam (Valium®)
Flurazepam (Dalmane®)
Clorazepate (Tranxene®)
Quazepam (Doral®)
Prazepam (Currently unavailable in the US)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chlordiazepoxide (Librium®)

A

1st benzodiazepine, used as an anxiolytic and for alcohol withdrawal, accumulation of
metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diazepam (Valium®)

A

Prototypical benzodiazepine, used as an anxiolytic, for alcohol withdrawal, and for
treatment of convulsive disorders (seizures), accumulation of metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Flurazepam (Dalmane®)

A

Used as a hypnotic, accumulation of metabolites

18
Q

Clorazepate (Tranxene®)

A

Used as an anxiolytic, for alcohol withdrawal, and for treatment of convulsive disorders, accumulation of metabolites

19
Q

Quazepam (Doral®)

A

Used as a hypnotic, accumulation of metabolites (good or bad for helping sleeping?

20
Q

Prazepam

A

slow elimination (Currently unavailable in the US) Used as an anxiolytic

21
Q

Drugs with Intermediate Elimination Rates?

A

Alprazolam (Xanax®)
Lorazepam (Ativan®)
Clonazepam (Klonopin®)
Oxazepam (Serax®)
Temazepam (Restoril®)

22
Q

Alprazolam (Xanax®)

A

Withdrawal symptoms can present if abrupt discontinuation occurs, used as an
anxiolytic and anesthetic

23
Lorazepam (Ativan®)
Used as an anxiolytic and as a hypnotic
24
Clonazepam (Klonopin®)
Tolerance may develop with prolonged use, used as an anticonvulsant
25
Oxazepam (Serax®)
Used as an anxiolytic and for alcohol withdrawal
26
Temazepam (Restoril®)
Used as a short-term hypnotic
27
Rapid Elimination Rates drugs
Midazolam (Versed) Triazolam (Halcion®, Discontinued)
28
Midazolam (Versed)
Rapid anesthesia
29
Triazolam (Halcion)
discontinued Used as a short-term hypnotic
30
Slow elimination benzos cause
accumulation active metabolites drowsiness and sedation useful in patients who wake up
31
intermediate to rapid benzos
Preferable in patients with hepatic problems Preferable in elderly patients Drugs that alter liver enzymes Rapid tolerance Rebound Insomnia
32
Properties of Benzos
Anxiolytic Sleep Physiology: Decrease REM, Decrease stage 3 and 4 (good or bad?), Tolerance and rebound to delta and REM Anticonvulsant activity Muscle relaxant Cardiovascular and respiratory depression (major issue when combine with other agents) Anterograde amnesia Unable to recall events that occurred
33
toxicology of benzos
Side Effects Dose dependent :Sedation, Confusion, Ataxia, Daytime Sedation( With longer acting agents tolerance develops) Weakness, Headache, Vertigo, Nausea, Paradoxical effects Precautions and Interactions: Other sedatives, Alcohol, Pregnancy and breast-feeding Drug Dependence and Abuse: Abuse Potential  Low vs barbiturates – Small “Kick” Often when in combination with other drugs of abuse
34
What is a benzodiazepine antagonist
Flumazenil (Romazicon®) treat BZD overdose Side Effects: Induce Convulsions*, Panic Attacks*, Agitation, Confusion,Nausea and Vomiting, Headache * For who developed dependence
35
Zolpidem (Ambien®, Ambien CRTM)
Short-term treatment of insomnia With difficulty of sleep-onset Ambien CRTM for sleep maintenance Ambien® and Ambien CRTM
35
Non-Benzodiazepines
Z-Hypnotics”: Act at BZD Binding Site (BZ1 receptor) Zolpidem (Ambien®, Ambien CRTM) Zaleplon (Sonata®) Eszopiclone (LunestaTM) CYP3A4 to some extent Overdose Treatment: Flumazenil (Romazicon®) Side Effects: Daytime drowsiness, dizziness, ataxia, nausea, and vomiting Cause less negative effects on sleep patterns vs. BZD Sleep-driving, sleep-cooking, sleep-eating, sleep-sex (FDA: warn your patient)
36
Zaleplon (Sonata®)
Short-term treatment of insomnia (7-10 days) Rapid acting, Rapidly eliminated Little tolerance or dependence
37
Eszopiclone (LunestaTM)
Active enantiomer of zopiclone 50 times greater affinity Treatment of insomnia Approved for long-term use
38
illicit use of Benzos
flunitrazepam and clonazepam and zolpidem
39
long acting barbiturates
Anticonvulsants – Phenobarbital (Luminal®) – Mephobarbital (Mebaral®
40
Short to Intermediate Acting barbiturates
Sedative-Hypnotics – Amobarbital (Amytal®) – Butabarbital (Butisol Sodium®) – Pentobarbital (Nembutal®) – Secobarbital (Seconal®) – Aprobarbital (Alurate®)
41
Ultra-Short Acting
IV Anesthetics – Thiopental (Pentothal®) – Methohexital (Brevital® Sodium) – Thiamylal (Surital®)
42
Pharmacology of Barbiturates
Sleep Physiology:Comparable to BZD, Decrease REM, Slow Deep Sleep Cardiovascular Depression at high doses Respiratory Depression death Enzyme Interactions: Compete for Cytochrome P450s for metabolism Enzyme Induction Anticonvulsant Idiosyncratic excitement and pain
43
Pharmacokinetics of Barbiturates
Duration of Action: Inversely proportional to lipid solubility Decrease of Activities: Metabolic transformations and redistribution Ultra-Short and Short Acting: Determined by redistribution Anesthetics Determined by lipid solubility and rapid redistribution Long Half-life: Accumulation
44
BZDvs BBT vs z-hypnotics
Barbiturtates (BBT): bind to all GABAA a1-5; Increase the duration of channel opening; and direct effects on GABAA channel (high doses); higher risk Benzodiazepines (BZDs): bind to all GABAA a1-5; Increase frequency of GABAA channel opening; medium risk Z-Hypnotics: bind to GABAA BZ1 receptors of a1; Increase frequency of GABAA channel opening; lower risk The use and limitation of Flumazenil